国际眼科杂志
國際眼科雜誌
국제안과잡지
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
2015年
4期
601-604
,共4页
小梁切除术%苏拉明%浓度%增殖细胞核抗原
小樑切除術%囌拉明%濃度%增殖細胞覈抗原
소량절제술%소랍명%농도%증식세포핵항원
trabeculetomy%suramin%concentration%proliferating cell nuclear antigen
目的:研究苏拉明的浓度改变对其在兔小梁切除术中作用效果的影响,为青光眼的治疗提供实验依据。<br> 方法:新西兰白兔32只随机分为四组:标准组、实验Ⅰ组、实验Ⅱ组和实验Ⅲ组,双眼均行标准小梁切除术。术中标准组于巩膜瓣下一次性应用0.3 mg/mL丝裂霉素C棉片2min,其它3组术中分别于巩膜瓣下一次性应用0.3,0.4,0.5 mg/mL苏拉明棉片2 min。分别在术后第3,7,15,30 d检查眼压、滤过泡情况,取滤过道附近组织分别行HE染色和免疫组化染色。<br> 结果:术后第7,15,30d,四组眼压、功能性滤过泡、PCNA染色阳性细胞核数比较,实验Ⅱ组和Ⅲ组与实验Ⅰ组和标准组比较,差异均有统计学意义(P<0.05);实验Ⅰ组与标准组的差异均无统计学意义(P>0.05)。实验Ⅲ组的眼压和PCNA 染色阳性细胞核数与实验Ⅱ组比较,差异均有统计学意义(P<0.05);实验Ⅲ组的功能性滤过泡与实验Ⅱ组比较,差异无统计学意义(P>0.05)。实验Ⅱ组和实验Ⅲ组的滤过道均清晰可见,滤过道开放程度均高于标准组和实验I组。<br> 结论:苏拉明的浓度对其在兔小梁切除术中的作用效果有显著影响。0.3 mg/mL苏拉明的作用效果与MMC相当;0.4,0.5mg/mL苏拉明的作用效果显著优于MMC;0.5mg/mL苏拉明的降眼压和抑制成纤维细胞增殖的效果优于0.4 mg/mL苏拉明。
目的:研究囌拉明的濃度改變對其在兔小樑切除術中作用效果的影響,為青光眼的治療提供實驗依據。<br> 方法:新西蘭白兔32隻隨機分為四組:標準組、實驗Ⅰ組、實驗Ⅱ組和實驗Ⅲ組,雙眼均行標準小樑切除術。術中標準組于鞏膜瓣下一次性應用0.3 mg/mL絲裂黴素C棉片2min,其它3組術中分彆于鞏膜瓣下一次性應用0.3,0.4,0.5 mg/mL囌拉明棉片2 min。分彆在術後第3,7,15,30 d檢查眼壓、濾過泡情況,取濾過道附近組織分彆行HE染色和免疫組化染色。<br> 結果:術後第7,15,30d,四組眼壓、功能性濾過泡、PCNA染色暘性細胞覈數比較,實驗Ⅱ組和Ⅲ組與實驗Ⅰ組和標準組比較,差異均有統計學意義(P<0.05);實驗Ⅰ組與標準組的差異均無統計學意義(P>0.05)。實驗Ⅲ組的眼壓和PCNA 染色暘性細胞覈數與實驗Ⅱ組比較,差異均有統計學意義(P<0.05);實驗Ⅲ組的功能性濾過泡與實驗Ⅱ組比較,差異無統計學意義(P>0.05)。實驗Ⅱ組和實驗Ⅲ組的濾過道均清晰可見,濾過道開放程度均高于標準組和實驗I組。<br> 結論:囌拉明的濃度對其在兔小樑切除術中的作用效果有顯著影響。0.3 mg/mL囌拉明的作用效果與MMC相噹;0.4,0.5mg/mL囌拉明的作用效果顯著優于MMC;0.5mg/mL囌拉明的降眼壓和抑製成纖維細胞增殖的效果優于0.4 mg/mL囌拉明。
목적:연구소랍명적농도개변대기재토소량절제술중작용효과적영향,위청광안적치료제공실험의거。<br> 방법:신서란백토32지수궤분위사조:표준조、실험Ⅰ조、실험Ⅱ조화실험Ⅲ조,쌍안균행표준소량절제술。술중표준조우공막판하일차성응용0.3 mg/mL사렬매소C면편2min,기타3조술중분별우공막판하일차성응용0.3,0.4,0.5 mg/mL소랍명면편2 min。분별재술후제3,7,15,30 d검사안압、려과포정황,취려과도부근조직분별행HE염색화면역조화염색。<br> 결과:술후제7,15,30d,사조안압、공능성려과포、PCNA염색양성세포핵수비교,실험Ⅱ조화Ⅲ조여실험Ⅰ조화표준조비교,차이균유통계학의의(P<0.05);실험Ⅰ조여표준조적차이균무통계학의의(P>0.05)。실험Ⅲ조적안압화PCNA 염색양성세포핵수여실험Ⅱ조비교,차이균유통계학의의(P<0.05);실험Ⅲ조적공능성려과포여실험Ⅱ조비교,차이무통계학의의(P>0.05)。실험Ⅱ조화실험Ⅲ조적려과도균청석가견,려과도개방정도균고우표준조화실험I조。<br> 결론:소랍명적농도대기재토소량절제술중적작용효과유현저영향。0.3 mg/mL소랍명적작용효과여MMC상당;0.4,0.5mg/mL소랍명적작용효과현저우우MMC;0.5mg/mL소랍명적강안압화억제성섬유세포증식적효과우우0.4 mg/mL소랍명。
AIM:To investigate the effect of suramin concentration changes on trabeculectomy in rabbit, and to provide treatment strategies for glaucoma on the basis of experiment. <br> METHODS:Thirty-two albino rabbits were randomly divided into four groups, including standard control group, experimental group Ⅰ, experimental group II, and experimental group Ⅲ. Each eye was performed standard trabeculectomy. During surgery, standard control group was given a piece of cotton with 0. 3mg/mL mitomycin C ( MMC ) for 2min, and the other three groups were given a piece of cotton with 0. 3, 0. 4, and 0.5mg/mL suramin respectively for 2min. The filtering blebs and intraocular pressure ( IOP ) were observed at the 3, 7, 15, and 30d after surgery. Some conjunctiral specimen were observed with hitochemicall ( HE staining) and immunohistochemicall methods. <br> RESULTS:At postoperative 7, 15, and 30d, the changes of the IOP, functional filtering blebs, and the number of positive cell nuclear in experimental group II and experimental group Ⅲ were significantly different compared with those in standard control group and experimental group Ⅰ (all P<0. 05), and the differences between experimental group Ⅰ and standard control group were not significant (P>0. 05). The changes of the IOP and the number of positive cell nuclear in experimental group Ⅲ were significantly different compared with those in experimental group II (P<0. 05), whereas the differences in functional filtering blebs between experimental group Ⅲ and experimental groupII were not significant (P>0. 05). The status of filtering channel in experimental groupII and experimental group <br> Ⅲ were better than those in experimental group Ⅰ and standard control group. <br> CONCLUSION: The concentration of suramin has a significantly influence on its effect. When the concentration is 0. 3mg/mL, the antiproliferative effect of suramin is no more than that of MMC. The effect of 0. 4, 0.5mg/mL suramin is better than MMC. 0. 5mg/mL suramin has a better effect on controlling IOP and suppressing the growth of fibroblasts than 0. 4mg/mL suramin.